James R. Black

6.4k total citations
56 papers, 2.4k citations indexed

About

James R. Black is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, James R. Black has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Surgery. Recurrent topics in James R. Black's work include Cancer Genomics and Diagnostics (8 papers), Pluripotent Stem Cells Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). James R. Black is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Pluripotent Stem Cells Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). James R. Black collaborates with scholars based in United Kingdom, United States and Italy. James R. Black's co-authors include James A. Ross, David C. Hay, Nicholas McGranahan, Judy Fletcher, John P. Iredale, Charles Swanton, Krijn K. Dijkstra, Chris Bailey, Joanna Przewrocka and Simon J. Clark and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

James R. Black

56 papers receiving 2.4k citations

Peers

James R. Black
Robin D. Kim United States
Philip Y. Wai United States
Gerald S. Lipshutz United States
Yizhou Jiang United States
Susan Yung Hong Kong
Daniel C. Adelman United States
Robin D. Kim United States
James R. Black
Citations per year, relative to James R. Black James R. Black (= 1×) peers Robin D. Kim

Countries citing papers authored by James R. Black

Since Specialization
Citations

This map shows the geographic impact of James R. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Black more than expected).

Fields of papers citing papers by James R. Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Black. The network helps show where James R. Black may publish in the future.

Co-authorship network of co-authors of James R. Black

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Black. A scholar is included among the top collaborators of James R. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Black. James R. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puttick, Clare, Michelle Leung, Felipe Gálvez‐Cancino, et al.. (2024). MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nature Genetics. 56(10). 2121–2131. 15 indexed citations
2.
Abbosh, Chris, Darren Hodgson, Gary J. Doherty, et al.. (2024). Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer. Trends in cancer. 10(7). 643–654. 18 indexed citations
3.
Karras, Panagiotis, James R. Black, Nicholas McGranahan, & Jean‐Christophe Marine. (2024). Decoding the interplay between genetic and non-genetic drivers of metastasis. Nature. 629(8012). 543–554. 16 indexed citations
4.
Black, James R., Alexander M. Frankell, Selvaraju Veeriah, et al.. (2023). LBA55 An ultra-sensitive and specific ctDNA assay provides novel pre-operative disease stratification in early stage lung cancer. Annals of Oncology. 34. S1294–S1294. 6 indexed citations
5.
Cox, Kate, Anna Knack, Martin Robson, et al.. (2020). A Changing Climate: Exploring the Implications of Climate Change for UK Defence and Security. RAND Corporation eBooks. 3 indexed citations
6.
Black, James R., Chris Bailey, Joanna Przewrocka, Krijn K. Dijkstra, & Charles Swanton. (2020). COVID-19: the case for health-care worker screening to prevent hospital transmission. The Lancet. 395(10234). 1418–1420. 268 indexed citations
7.
Pinato, David J., Robert J. Shiner, James R. Black, et al.. (2016). Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy. OncoImmunology. 5(9). e1213934–e1213934. 65 indexed citations
8.
Pinato, David J., et al.. (2016). Peptide receptor radionuclide therapy for metastatic paragangliomas. Medical Oncology. 33(5). 47–47. 37 indexed citations
9.
Brown, Matthew, James R. Black, Rohini Sharma, Justin Stebbing, & David J. Pinato. (2016). Gene of the month:Axl. Journal of Clinical Pathology. 69(5). 391–397. 29 indexed citations
10.
Black, James R., et al.. (2013). Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment. Bioorganic & Medicinal Chemistry. 22(2). 756–761. 33 indexed citations
11.
Hannoun, Zara, Judy Fletcher, Sebastian Greenhough, et al.. (2010). The Comparison between Conditioned Media and Serum-Free Media in Human Embryonic Stem Cell Culture and Differentiation. Cellular Reprogramming. 12(2). 133–140. 34 indexed citations
12.
Hay, David C., Salvatore Pernagallo, Juan J. Díaz‐Mochón, et al.. (2010). Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Research. 6(2). 92–102. 70 indexed citations
13.
Hay, David C., Salvatore Pernagallo, Juan J. Díaz‐Mochón, et al.. (2009). A SIMPLE POLYURETHANE MATRIX PROMOTES HEPATIC ENDODERM VIABILITY AND INDUCIBLE DRUG METABOLISM: IMPLICATIONS FOR DRUG TOXICOLOGY TESTING AND THE DESIGN OF LIVER SUPPORT DEVICES. Hepatology. 50(6). 1 indexed citations
14.
Sullivan, Gareth J., David C. Hay, In-Hyun Park, et al.. (2009). Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells. Hepatology. 51(1). 329–335. 308 indexed citations
15.
Fletcher, Judy, Wei Cui, Kay Samuel, et al.. (2008). The Inhibitory Role of Stromal Cell Mesenchyme on Human Embryonic Stem Cell Hepatocyte Differentiation is Overcome by Wnt3a Treatment. Cloning and Stem Cells. 10(3). 331–340. 19 indexed citations
16.
Black, James R., et al.. (1996). SKIN DISORDERS OF THE LOWER EXTREMITY IN ADULTS AS REPORTED IN THE CURRENT LITERATURE. Clinics in Podiatric Medicine and Surgery. 13(1). 109–117. 1 indexed citations
17.
Black, James R., et al.. (1993). HEEL PAIN IN THE OLDER PATIENT. Clinics in Podiatric Medicine and Surgery. 10(1). 113–119. 1 indexed citations
18.
Black, James R., et al.. (1987). Kaposi's sarcoma of the lower extremity. A case report. Journal of the American Podiatric Medical Association. 77(2). 89–92. 1 indexed citations
19.
Black, James R., et al.. (1987). Implanted gentamicin beads in the treatment of osteomyelitis. A case report. Journal of the American Podiatric Medical Association. 77(10). 563–566. 2 indexed citations
20.
Black, James R., et al.. (1983). Tumoral calcinosis in the foot and hand. A case report. Journal of the American Podiatric Medical Association. 73(3). 153–155. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026